I've just purchased shares so not frustrated. So coming at this with a fresh perspective.
I think the fundamentals are pretty good here.
They have;
* ~$16m in cash on a $30m market up, so an EV of $14m
* Just produced a $5.2m of NPAT (5.8 x P/E)
* EV/EBITDA (using PBT as quick proxy) of $7.2m (EV/EBITDA multiple of ~1.94x)
* 2x book value
* 20 year track record of outperformance and a new distribution team (that has real value)
* they fixed the managment fees which caused the outflows (taken the pain)
* back with positive research ratings, back on some platforms
Yes, FUM has been falling but if you take the view that with such a good track record they'll eventually get back to growing FUM, this thing coudl do really well again.
Very leverage upside on FUM growth.
For every $100m of FUM they can add is $1.5m in revenue and $1.0m NPAT
(and yes the CEO pays himself too much)
- Forums
- ASX - By Stock
- KAM
- Ann: Appendix 4E and Annual Report - 30 June 2018
Ann: Appendix 4E and Annual Report - 30 June 2018, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KAM (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.05M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 6.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 24020 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 0.071 |
2 | 163100 | 0.070 |
1 | 23000 | 0.066 |
1 | 60000 | 0.063 |
1 | 100000 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 50000 | 1 |
0.081 | 22275 | 2 |
0.082 | 11500 | 1 |
0.085 | 45971 | 1 |
0.089 | 2700 | 1 |
Last trade - 11.00am 25/11/2024 (20 minute delay) ? |
Featured News
KAM (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online